AP Gets First TomoTherapy Radixact X9: Revolutionizing Cancer Treatment at MGCHRI

• Mahatma Gandhi Cancer Hospital & Research Institute (MGCHRI), Visakhapatnam, launches TomoTherapy Radixact X9, first in Andhra Pradesh.
• Radixact X9 combines CT scan with 360-degree radiation delivery, offering adaptive radiotherapy that adjusts daily for precision.
• Minimizes radiation exposure to healthy tissues, significantly reducing side effects and accelerating patient recovery.
• Effective for complex cases, delicate organs in children, and simplifies specialized treatments like Total Body Irradiation (TBI) and Total Marrow Irradiation (TMI).
• Offers patients precision, less pain, shorter treatment duration, and higher safety standards, strengthening MGCHRI's position.

Why It Matters: MGCHRI introduces AP's first TomoTherapy Radixact X9, offering precise, safer cancer treatment.